Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gingival tissue healing promotion refers to the set of therapeutic strategies, compounds, and biological processes intended to accelerate and enhance the healing of the gingival tissue following injury, surgery, or disease. Gingival wound healing displays distinct properties compared to skin healing, notably reduced scarring and faster re-epithelialization. The process involves proliferation and migration of keratinocytes and fibroblasts, angiogenesis, and modulation of inflammatory responses, orchestrated by many growth factors and signaling pathways such as TGF-β, PDGF, FGF, and IGF. Various drugs and biopharmaceuticals (like enamel matrix derivatives and platelet concentrates) target these pathways to improve healing outcomes. However, "Gingival tissue healing promotion" itself is not a molecule, receptor, or gene, but rather a description of an overall process or therapeutic goal[1][2][3][4][5][6].
Stimulation of fibroblast and epithelial cell proliferation. Activation of growth factor signaling pathways (TGF-β, PDGF, FGF, EGF, IGF). Modulation of inflammation and angiogenesis. Induction of extracellular matrix production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gingival tissue healing promotion.